Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
Public ClinicalTrials.gov record NCT00501241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
Study identification
- NCT ID
- NCT00501241
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Procter and Gamble
- Industry
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Interventions
- ATI-7505 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- Jun 30, 2008
- Completion
- Jun 30, 2008
- Last update posted
- Jun 16, 2009
2007 – 2008
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Facility | Anaheim | California | — | — |
| Research facility | San Carlos | California | — | — |
| Research Facility | San Diego | California | — | — |
| Research Facility | Littleton | Colorado | — | — |
| Research Facility | Aventura | Florida | — | — |
| Research Facility | Hollywood | Florida | — | — |
| Research Facility | South Miami | Florida | — | — |
| Researrch Facility | Newnan | Georgia | — | — |
| Research Facility | Rockford | Illinois | — | — |
| Research Facility | Evansville | Indiana | — | — |
| Research Facility | Boston | Massachusetts | — | — |
| Research Facility | Great Neck | New York | — | — |
| Research Facility | Lake Success | New York | — | — |
| Research Facility | Cincinnati | Ohio | — | — |
| Research Facility | Oklahoma City | Oklahoma | — | — |
| Research Facility | Chattanooga | Tennessee | — | — |
| Research Facility | Nashville | Tennessee | — | — |
| Research Facility | Salt Lake City | Utah | — | — |
| Research Facility | Charlottesville | Virginia | — | — |
| Research Facility | Christiansburg | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00501241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2009 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00501241 live on ClinicalTrials.gov.